OTC Tests For Flu, Strep, STIs Up For Discussion At FDA Panel Meeting
Executive Summary
Panelists will look at the benefits and risks of over-the-counter diagnostics for influenza, strep throat and sexually transmitted infections. The meeting is being held in response to sponsor queries about new test designs.
You may also be interested in...
US FDA Panel Sees Benefits To OTC Pathogen Tests, But Urges Caution
An FDA panel concluded Aug. 16 that the benefits of over-the-counter tests for influenza, strep throat and certain sexually transmitted infections would likely outweigh the risks. But the group urged developers to take care in ensuring that the test results were easy for patients to interpret.
OraSure Preps October Launch Of First-Ever In-Home HIV Test
Firm gains PMA approval for OraQuick July 3, making it the first available HIV test that can be performed entirely in the home by untrained users.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.